{"transactions":[{"id":832718,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Options (right to buy)","published_at":"2026-03-20T21:20:05.000Z","date":"2026-03-18","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":2.8,"value":7000.0,"ownership":{"direct":true},"balance_after":21000,"derivative":{"exercise_price":2.8,"exercise_date":"2030-03-18","expiration_date":"2036-03-18","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001572342-26-000002","document":"wk-form4_1774041602.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000157234226000002/wk-form4_1774041602.xml","form_type":"4"}},{"id":1201684,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Options (right to buy)","published_at":"2025-03-18T21:11:50.000Z","date":"2025-03-17","kind":"grant","planned":false,"acquired":true,"shares":2500,"price":5.17,"value":12925.0,"ownership":{"direct":true},"balance_after":18500,"derivative":{"exercise_price":5.17,"exercise_date":"2029-03-17","expiration_date":"2035-03-17","underlying":"Common Stock","underlying_shares":2500},"source":{"system":"sec-edgar","filing":"0001628280-25-013534","document":"wk-form4_1742332303.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000162828025013534/wk-form4_1742332303.xml","form_type":"4"}},{"id":1561037,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Options (right to buy)","published_at":"2024-03-27T00:26:03.000Z","date":"2024-03-25","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":1.71,"value":6840.0,"ownership":{"direct":true},"balance_after":16000,"derivative":{"exercise_price":1.71,"exercise_date":"2028-03-25","expiration_date":"2034-03-25","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001214659-24-005215","document":"marketforms-65386.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000121465924005215/marketforms-65386.xml","form_type":"4"}},{"id":1561036,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2024-03-27T00:26:03.000Z","date":"2024-03-23","kind":"tax_withholding","planned":false,"acquired":false,"shares":1186,"price":1.81,"value":2146.66,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":38255,"source":{"system":"sec-edgar","filing":"0001214659-24-005215","document":"marketforms-65386.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000121465924005215/marketforms-65386.xml","form_type":"4"}},{"id":1938310,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Options (right to buy)","published_at":"2023-03-27T21:47:20.000Z","date":"2023-03-24","kind":"grant","planned":false,"acquired":true,"shares":4000,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":12000,"derivative":{"exercise_price":1.97,"exercise_date":"2027-03-24","expiration_date":"2033-03-24","underlying":"Common Stock","underlying_shares":4000},"source":{"system":"sec-edgar","filing":"0001209191-23-021284","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919123021284/doc4.xml","form_type":"4"}},{"id":1943562,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2023-03-21T21:26:13.000Z","date":"2023-03-18","kind":"tax_withholding","planned":false,"acquired":false,"shares":1280,"price":1.92,"value":2457.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":39441,"source":{"system":"sec-edgar","filing":"0001209191-23-020346","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919123020346/doc4.xml","form_type":"4"}},{"id":2288132,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Options (right to buy)","published_at":"2022-04-29T17:04:36.000Z","date":"2022-03-16","kind":"grant","acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"100% vesting on March 16, 2026."}],"balance_after":6000,"derivative":{"exercise_price":2.59,"exercise_date":"2026-03-16","expiration_date":"2032-03-16","underlying":"Common Stock","underlying_shares":6000},"source":{"system":"sec-edgar","filing":"0001209191-22-026142","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919122026142/doc4.xml","form_type":"4"}},{"id":2288131,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2022-04-29T17:04:36.000Z","date":"2022-03-20","kind":"tax_withholding","acquired":false,"shares":1280,"price":2.74,"value":3507.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":40721,"source":{"system":"sec-edgar","filing":"0001209191-22-026142","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919122026142/doc4.xml","form_type":"4"}},{"id":2672560,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Options (right to buy)","published_at":"2021-06-11T21:12:52.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"100% vesting on March 17, 2025."}],"balance_after":3000,"derivative":{"exercise_price":3.22,"exercise_date":"2025-03-17","expiration_date":"2031-03-17","underlying":"Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001209191-21-039926","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919121039926/doc4.xml","form_type":"4"}},{"id":2672559,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2021-06-11T21:12:52.000Z","date":"2021-03-17","kind":"tax_withholding","acquired":false,"shares":2560,"price":3.22,"value":8243.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":45001,"source":{"system":"sec-edgar","filing":"0001209191-21-039926","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919121039926/doc4.xml","form_type":"4"}},{"id":3174607,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2020-04-17T21:17:33.000Z","date":"2020-03-23","kind":"grant","acquired":true,"shares":4000,"price":3.56,"value":14240.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Restricted stock award will vest 100% on March 23, 2024."}],"balance_after":44561,"source":{"system":"sec-edgar","filing":"0001209191-20-024878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919120024878/doc4.xml","form_type":"4"}},{"id":3174606,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2020-04-17T21:17:33.000Z","date":"2020-03-18","kind":"tax_withholding","acquired":false,"shares":1173,"price":3.53,"value":4140.69,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":40561,"source":{"system":"sec-edgar","filing":"0001209191-20-024878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919120024878/doc4.xml","form_type":"4"}},{"id":3356798,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2019-11-29T22:26:44.000Z","date":"2019-11-26","kind":"tax_withholding","acquired":false,"shares":2149,"price":4.93,"value":10594.57,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":41734,"source":{"system":"sec-edgar","filing":"0001209191-19-058442","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119058442/doc4.xml","form_type":"4"}},{"id":3582001,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2019-03-22T21:23:22.000Z","date":"2019-03-22","kind":"tax_withholding","acquired":false,"shares":2066,"price":5.62,"value":11610.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":43883,"source":{"system":"sec-edgar","filing":"0001209191-19-021051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119021051/doc4.xml","form_type":"4"}},{"id":3582000,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2019-03-22T21:23:22.000Z","date":"2019-03-22","kind":"grant","acquired":true,"shares":3000,"price":5.98,"value":17940.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 18, 2023."}],"balance_after":45949,"source":{"system":"sec-edgar","filing":"0001209191-19-021051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919119021051/doc4.xml","form_type":"4"}},{"id":3984188,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2018-03-23T21:45:27.000Z","date":"2018-03-23","kind":"tax_withholding","acquired":false,"shares":2999,"price":6.7,"value":20093.3,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents shares withheld/purchased by the Company to cover the tax withholding obligations for the vesting of shares."}],"balance_after":42949,"source":{"system":"sec-edgar","filing":"0001209191-18-021481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118021481/doc4.xml","form_type":"4"}},{"id":3984187,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2018-03-23T21:45:27.000Z","date":"2018-03-23","kind":"grant","acquired":true,"shares":3000,"price":6.7,"value":20100.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 20, 2022."}],"balance_after":45948,"source":{"system":"sec-edgar","filing":"0001209191-18-021481","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919118021481/doc4.xml","form_type":"4"}},{"id":4356245,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2017-04-07T20:58:21.000Z","date":"2017-04-07","kind":"tax_withholding","acquired":false,"shares":1796,"price":6.45,"value":11584.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents shares withheld by the Company to cover the tax withholding obligations for the vesting of 5,500 shares during March 2017."}],"balance_after":42948,"source":{"system":"sec-edgar","filing":"0001209191-17-026307","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117026307/doc4.xml","form_type":"4"}},{"id":4356244,"issuer":{"id":6757,"kind":"organization","name":"CUMBERLAND PHARMACEUTICALS INC"},"owners":[{"id":56919,"kind":"person","name":"Herman James L","position":1,"cik":"0001572342","reported_name":"Herman James L","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"VP and Chief Compliance Office"}}],"security":"Common Stock","published_at":"2017-04-07T20:58:21.000Z","date":"2017-04-07","kind":"grant","acquired":true,"shares":6000,"price":6.45,"value":38700.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Restricted stock award will vest 100% on March 17, 2021."}],"balance_after":44744,"source":{"system":"sec-edgar","filing":"0001209191-17-026307","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1087294/000120919117026307/doc4.xml","form_type":"4"}}]}